Search for: "United States v. Bartlett" Results 1 - 20 of 180
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Jul 2013, 5:00 am by Bexis
  He briefed Bartlett before the United States Supreme Court on behalf of the respondent/plaintiff, Ms. [read post]
19 Mar 2013, 6:58 am by Bexis
Bartlett, No. 12-142 – is being argued in the United States Supreme Court today. [read post]
30 Nov 2012, 2:00 pm by Bexis
As we had hoped, the United States Supreme Court agreed today to review the First Circuit's remarkable ruling in Mutual Pharmaceutical Co. v. [read post]
23 Jul 2010, 7:28 am by Bexis
Last Friday we had a brief post about the new decision in Bartlett v. [read post]
5 Jul 2013, 7:01 am by FDABlog HPM
Bartlett (Docket No. 12-0142) on June 24th, ruling that state-law design-defect claims that turn on the adequacy of a drug’s warnings are preempted by the FDC Act and under the Court’s 2011 decision in PLIVA Inc. v. [read post]
25 Jan 2013, 12:47 pm by Bexis
  We’ve received the same bone-headed response from an appellate court in a branded case, seeWimbush v. [read post]
29 Jun 2018, 5:58 am by CrimProf BlogEditor
United States: Whether to overrule the “separate sovereign” exception to the double jeopardy clause Nieves v. [read post]
4 Oct 2012, 10:40 am by William Young, Jr.
The United States Supreme Court recently announced that it will hear oral arguments on Missouri v. [read post]
20 May 2013, 7:02 am by FDABlog HPM
Bartlett (Docket No. 12-142), a design defect generic drug preemption case (see our previous post here), we thought we would whet the preemption appetite with two new petitions to the Supreme Court and an interesting state court decision. [read post]
31 Jan 2019, 6:06 pm by Timothy P. Flynn
The collateral civil litigation in Arctic Man claims that the subject of such an arrest was merely exercising his right to free speech under the First Amendment to the United States Constitution. [read post]
In Morrison, the Supreme Court limited investors’ ability to bring private 10b-5 securities fraud actions to cases where the securities at issue were purchased on a United States stock exchange or were otherwise purchased in the U.S. [read post]